Ys Biopharma Co. Ltd (YS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YS | ACTU | BMEA | ||
| Company | Ys Biopharma Co. Ltd | Actuate Therapeutics Inc | Biomea Fusion Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.9000 | 4.22 | 1.3000 | ||
| High | 1.1000 | 4.49 | 1.3700 | ||
| Low | 0.9000 | 4.13 | 1.2850 | ||
| Latest | 1.0200 | 4.13 | 1.3200 | ||
| Change | +0.1129 | -0.11 | unch | ||
| % Change | +12.45% | -2.59% | unch | ||
| Volume | 107,200 | 52,300 | 758,800 | ||
| 20-Day Average Volume | 81,165 | 56,785 | 1,037,295 | ||
| Previous Close | 0.9071 | 4.24 | 1.3200 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.8888 | 4.61 | 1.2420 | ||
| 20-Day Raw Stochastic | 79.80% | 5.23% | 72.50% | ||
| 20-Day Relative Strength | 60.44 | 32.90 | 51.47 | ||
| Weighted Alpha | -21.89 | -54.61 | -63.60 | ||
| Today's Opinion | 88% Buy | 100% Sell | 72% Sell | ||
| Previous Opinion | 88% Buy | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 48% Buy | 100% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.31% since 05/17/24 | -2.59% since 02/12/26 | +5.60% since 02/12/26 | ||
| Low | 0.8810 on 05/22/24 | 4.06 on 02/19/26 | 1.2400 on 02/13/26 | ||
| High | 1.1000 on 05/24/24 | 4.49 on 02/20/26 | 1.3700 on 02/20/26 | ||
| 1-Month | |||||
| %Chg | +25.93% since 04/24/24 | -25.72% since 01/20/26 | -4.35% since 01/20/26 | ||
| Low | 0.7040 on 04/30/24 | 4.04 on 02/12/26 | 1.0300 on 02/04/26 | ||
| High | 1.1000 on 05/24/24 | 5.89 on 01/22/26 | 1.4794 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +158.29% since 02/23/24 | -32.18% since 11/20/25 | +32.00% since 11/20/25 | ||
| Low | 0.3800 on 03/01/24 | 4.04 on 02/12/26 | 0.8719 on 11/21/25 | ||
| High | 1.1000 on 05/24/24 | 7.90 on 12/10/25 | 1.6600 on 01/15/26 | ||
| 6-Month | |||||
| %Chg | +63.51% since 11/24/23 | -46.19% since 08/20/25 | -25.84% since 08/20/25 | ||
| Low | 0.3503 on 02/02/24 | 4.04 on 02/12/26 | 0.8719 on 11/21/25 | ||
| High | 1.1000 on 05/24/24 | 9.22 on 09/04/25 | 2.9900 on 10/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 94,919 | 95,994 | 93,329 | ||
| Shares Outstanding, K | 93,058 | 23,243 | 70,704 | ||
| Annual Sales | 100,000,000 | 0 | 0 | ||
| Annual Net Income | -21,170,000 | -27,290,000 | -138,430,000 | ||
| Last Quarter Sales | 13,640,000 | 0 | 0 | ||
| Last Quarter Net Income | -14,680,000 | -5,410,000 | -16,410,000 | ||
| 60-Month Beta | 0.51 | -0.16 | -0.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 04/19/24 | -0.25 on 11/13/25 | -0.27 on 11/04/25 | ||
| Latest Earnings Date | 04/19/24 | 03/12/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||